These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3605254)

  • 21. Placental transfer of the thromboxane synthetase inhibitor ridogrel in the late-pregnant ewe.
    Schneider TJ; Struijk PC; Wallenburg HC
    Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):83-7. PubMed ID: 10471147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts.
    Freeman MB; Sicard GA; Valentin LI; Neuberger S; Mangino MJ; Anderson CB
    J Vasc Surg; 1988 Apr; 7(4):554-61. PubMed ID: 3127601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of thromboxane synthetase inhibitor (OKY-046) on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats.
    Furuhashi N; Tsujiei M; Kimura H; Nagae H; Yajima A
    Gynecol Obstet Invest; 1993; 35(1):23-6. PubMed ID: 8449429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate (U-63557A), a new, selective thromboxane synthase inhibitor: intravenous and oral pharmacokinetics in dogs and correlations with ex situ thromboxane B2 production.
    Wynalda MA; Liggett WF; Fitzpatrick FA
    Prostaglandins; 1983 Aug; 26(2):311-24. PubMed ID: 6685888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of thromboxane synthase inhibition on tumor necrosis factor-induced lung injury in sheep.
    Koizumi T; Kubo K; Kobayashi T; Sekiguchi M
    J Appl Physiol (1985); 1992 Aug; 73(2):618-24. PubMed ID: 1399989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The protective effect of thromboxane synthetase inhibition on renal function in systemic sepsis.
    Cumming AD; McDonald JW; Lindsay RM; Solez K; Linton AL
    Am J Kidney Dis; 1989 Feb; 13(2):114-9. PubMed ID: 2916566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
    Ohnishi A; Ishizaki T; Echizen H; Yasuda K; Fujiwara H; Tanaka T
    Clin Pharmacol Ther; 1992 Apr; 51(4):454-64. PubMed ID: 1563215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.
    Ghuysen A; Lambermont B; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Magis D; Hanson J; Segers P; D'Orio V
    J Pharmacol Exp Ther; 2004 Sep; 310(3):964-72. PubMed ID: 15121765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction.
    Hock CE; Phillips GR; Lefer AM
    Prostaglandins Leukot Med; 1985 Mar; 17(3):339-46. PubMed ID: 3857643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study.
    Moutquin JM; Lindsay C; Arial N; De Grandpré P; C-Gaudreault R; Forest JC; Massé J
    Am J Obstet Gynecol; 1997 Dec; 177(6):1483-90. PubMed ID: 9423755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
    Fitzgerald DJ; Fragetta J; FitzGerald GA
    J Clin Invest; 1988 Nov; 82(5):1708-13. PubMed ID: 3183064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboxane synthase activity and platelet function after furegrelate administration in man.
    Mohrland JS; Vander Lugt JT; Gorman RR; Lakings DB
    J Clin Pharmacol; 1989 Jan; 29(1):53-8. PubMed ID: 2708549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.
    Galipeau D; Arikawa E; Sekirov I; McNeill JH
    Hypertension; 2001 Oct; 38(4):872-6. PubMed ID: 11641301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ridogrel on the prostacyclin-thromboxane ratio in nulliparous third trimester-pregnant rhesus monkeys.
    Keith JC; Goodrich JA; Endo Y; Taub D; Mehlman P; Ward G
    Prostaglandins; 1993 Jun; 45(6):547-55. PubMed ID: 8337414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostacyclin in pregnancy.
    Spitz B; Deckmyn H; Van Assche FA; Vermylen J
    Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):303-8. PubMed ID: 6441731
    [No Abstract]   [Full Text] [Related]  

  • 36. Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep.
    Morel DR; Skoskiewicz M; Robinson DR; Bloch KJ; Hoaglin DC; Zapol WM
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H782-92. PubMed ID: 1716064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy.
    Hora K; Oguchi H; Furukawa T; Hora K; Tokunaga S
    Nephron; 1990; 56(3):297-305. PubMed ID: 2077412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
    Ambler J; Butler KD; Ku EC; Maguire ED; Smith JR; Wallis RB
    Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.